Instil Bio Net Worth
Instil Bio Net Worth Breakdown | TIL |
Instil Bio Net Worth Analysis
Instil Bio's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Instil Bio's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Instil Bio's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Instil Bio's net worth analysis. One common approach is to calculate Instil Bio's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Instil Bio's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Instil Bio's net worth. This approach calculates the present value of Instil Bio's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Instil Bio's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Instil Bio's net worth. This involves comparing Instil Bio's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Instil Bio's net worth relative to its peers.
Enterprise Value |
|
To determine if Instil Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Instil Bio's net worth research are outlined below:
| Instil Bio is way too risky over 90 days horizon | |
| Instil Bio appears to be risky and price may revert if volatility continues | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (74.14 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (55.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a very weak financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Silver Storm Announces Till Capital Shareholder Approval of Arrangement |
Instil Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Instil Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Instil Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Instil Bio Target Price Consensus
Instil target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Instil Bio's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Instil analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Instil stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Instil Bio, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationInstil Bio Target Price Projection
Instil Bio's current and average target prices are 27.62 and 118.67, respectively. The current price of Instil Bio is the price at which Instil Bio is currently trading. On the other hand, Instil Bio's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Instil Bio Target Price
Know Instil Bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Instil Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Instil Bio backward and forwards among themselves. Instil Bio's institutional investor refers to the entity that pools money to purchase Instil Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2025-03-31 | 77.3 K | Velan Capital Investment Management Lp | 2025-03-31 | 69 K | Blackrock Inc | 2025-03-31 | 58 K | Assenagon Asset Management Sa | 2025-06-30 | 57.5 K | Geode Capital Management, Llc | 2025-03-31 | 43.2 K | Adage Capital Partners Gp Llc | 2025-03-31 | 40 K | Vr Adviser, Llc | 2025-03-31 | 33.2 K | Fred Alger Management, Llc | 2025-03-31 | 31.3 K | Adar1 Capital Management Llc | 2025-03-31 | 24.3 K | Vivo Capital, Llc | 2025-03-31 | 585.5 K | Bml Capital Management Llc | 2025-03-31 | 416.7 K |
Follow Instil Bio's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 171.21 M.Market Cap |
|
Project Instil Bio's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.28) | (0.30) | |
| Return On Equity | (0.44) | (0.42) |
When accessing Instil Bio's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Instil Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Instil Bio's profitability and make more informed investment decisions.
Evaluate Instil Bio's management efficiency
Instil Bio has Return on Asset of (0.1259) % which means that on every $100 spent on assets, it lost $0.1259. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.445) %, meaning that it generated no profit with money invested by stockholders. Instil Bio's management efficiency ratios could be used to measure how well Instil Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.3. The value of Return On Capital Employed is expected to slide to -0.3. At this time, Instil Bio's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 670.4 M this year, although the value of Other Current Assets will most likely fall to about 11 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 26.03 | 28.58 | |
| Tangible Book Value Per Share | 26.03 | 27.86 | |
| Enterprise Value Over EBITDA | (3.29) | (3.45) | |
| Price Book Value Ratio | 0.73 | 0.77 | |
| Enterprise Value Multiple | (3.29) | (3.45) | |
| Price Fair Value | 0.73 | 0.77 | |
| Enterprise Value | 202.4 M | 192.2 M |
The operational strategies employed by Instil Bio management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Instil Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Instil Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Instil Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Instil Bio Corporate Filings
F4 | 29th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 28th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 15th of May 2025 Other Reports | ViewVerify | |
| 2nd of May 2025 Other Reports | ViewVerify |
Instil Bio Earnings per Share Projection vs Actual
Instil Bio Corporate Management
| Sandeep MD | CFO Officer | Profile | |
| Timothy Moore | Chief Officer | Profile | |
| Bronson Crouch | Chairman CEO | Profile | |
| Sumita JD | Compliance, Legal | Profile | |
| James MD | Chief Officer | Profile | |
| Mark Dudley | Chief Officer | Profile | |
| Robert MBBS | Head Development | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.